A number of firms have modified their ratings and price targets on shares of Encompass Health (NYSE: EHC) recently:
- 11/2/2026 – Encompass Health was given a new $155.00 price target by Mizuho.
- 10/31/2026 – Encompass Health was upgraded by Wall Street Zen from “hold” to “buy”.
- 10/30/2026 – Encompass Health had its “strong-buy” rating reaffirmed by Raymond James Financial. They now have a $155.00 price target on the stock.
- 10/30/2026 – Encompass Health had its price target raised by UBS Group from $155.00 to $165.00. They now have a “buy” rating on the stock.
- 10/30/2026 – Encompass Health had its price target raised by KeyCorp from $147.00 to $150.00. They now have an “overweight” rating on the stock.
- 10/30/2026 – Encompass Health had its “buy” rating reaffirmed by Truist Financial. They now have a $156.00 price target on the stock, up from $150.00.
- 10/30/2026 – Encompass Health had its price target raised by TD Cowen from $140.00 to $150.00. They now have a “buy” rating on the stock.
- 10/29/2026 – Encompass Health had its price target raised by Barclays from $144.00 to $151.00. They now have an “overweight” rating on the stock.
- 10/17/2026 – Encompass Health was downgraded by Wall Street Zen from “buy” to “hold”.
- 10/8/2026 – Encompass Health was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
- 9/28/2026 – Encompass Health was given a new $150.00 price target by Raymond James Financial.
- 9/26/2026 – Encompass Health was upgraded by Wall Street Zen from “hold” to “buy”.
Encompass Health Price Performance
Shares of NYSE EHC opened at $142.38 on Thursday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.73. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $143.61. The business has a 50 day moving average price of $125.94 and a two-hundred day moving average price of $111.58. The firm has a market cap of $13.97 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 2.47 and a beta of 0.83.
Encompass Health (NYSE:EHC – Get Free Report) last announced its earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.16. Encompass Health had a return on equity of 18.35% and a net margin of 10.17%. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same period in the prior year, the company posted $1.23 EPS. Encompass Health’s quarterly revenue was up 8.9% on a year-over-year basis. Sell-side analysts expect that Encompass Health Corporation will post 6.29 earnings per share for the current fiscal year.
Encompass Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, January 4th. Encompass Health’s dividend payout ratio is 13.12%.
Insider Buying and Selling
In other Encompass Health news, EVP John Darby sold 4,858 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at $9,086,714.69. This trade represents a 6.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by company insiders.
Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.
Read More
- Five stocks we like better than Encompass Health
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Encompass Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
